Cargando…

Codelivery of BCL2 and MCL1 Inhibitors Enabled by Phenylboronic Acid‐Functionalized Polypeptide Nanovehicles for Synergetic and Potent Therapy of Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is the most refractory hematologic malignancy characterized by acute onset, rapid progression, and high recurrence rate. Here, codelivery of BCL2 (ABT199) and MCL1 (TW37) inhibitors using phenylboronic acid‐functionalized polypeptide nanovehicles to achieve synergetic an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Jiguo, Zhao, Xiaofei, Zhang, Peng, Zhang, Yueyue, Cheng, Ru, Zhong, Zhiyuan, Deng, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015845/ https://www.ncbi.nlm.nih.gov/pubmed/36683178 http://dx.doi.org/10.1002/advs.202204866

Ejemplares similares

Aptamer-functionalized peptide H(3)CR(5)C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma
por: Liu, Ying, et al.
Publicado: (2016)

Advanced Nanovehicles-Enabled Delivery Systems of Epigallocatechin Gallate for Cancer Therapy
por: Li, Kai, et al.
Publicado: (2020)

Computational design of an apoptogenic protein that binds BCL-xL and MCL-1 simultaneously and potently
por: Kim, Seonghoon, et al.
Publicado: (2022)

Graphene-based nanovehicles for photodynamic medical therapy
por: Li, Yan, et al.
Publicado: (2015)

Norepinephrine transporter-derived homing peptides enable rapid endocytosis of drug delivery nanovehicles into neuroblastoma cells
por: Haddad, Yazan, et al.
Publicado: (2020)

Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
por: Moujalled, Donia M., et al.
Publicado: (2018)

Codelivery of Doxorubicin and Paclitaxel by Cross-Linked Multilamellar Liposome Enables Synergistic Antitumor Activity
por: Liu, Yarong, et al.
Publicado: (2014)

Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence
por: Liu, Zheng, et al.
Publicado: (2022)

Recent Advances in pH- or/and Photo-Responsive Nanovehicles
por: Shin, Yuseon, et al.
Publicado: (2021)

Rational designing of glyco-nanovehicles to target cellular heterogeneity
por: Jain, Prashant, et al.
Publicado: (2021)

Nanomedicine-enabled chemotherapy-based synergetic cancer treatments
por: Wu, Wencheng, et al.
Publicado: (2022)

Inhibition of Antiapoptotic BCL-XL, BCL-2, and MCL-1 Proteins by Small Molecule Mimetics
por: Dalafave, D.S., et al.
Publicado: (2010)

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
por: Lee, Erinna F., et al.
Publicado: (2019)

Preparation, characterization and in vitro–in vivo evaluation of bortezomib supermolecular aggregation nanovehicles
por: Chen, Ming-yue, et al.
Publicado: (2020)

Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 Inhibitors
por: Davis, Owen A., et al.
Publicado: (2022)

Large strain synergetic material deformation enabled by hybrid nanolayer architectures
por: Li, Jianjun, et al.
Publicado: (2017)

Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes
por: Seiller, Carolane, et al.
Publicado: (2020)

Inorganic Nanovehicle Targets Tumor in an Orthotopic Breast Cancer Model
por: Choi, Goeun, et al.
Publicado: (2014)

Ferritin nanovehicle for targeted delivery of cytochrome C to cancer cells
por: Macone, Alberto, et al.
Publicado: (2019)

RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy
por: Li, Nuannuan, et al.
Publicado: (2021)

Phenylboronic Acid-Mediated Tumor Targeting of Chitosan Nanoparticles
por: Wang, Xin, et al.
Publicado: (2016)

Surface defect engineered-Mg-based implants enable the dual functions of superhydrophobic and synergetic photothermal/chemodynamic therapy
por: Zhang, Dongdong, et al.
Publicado: (2023)

Poly(β-amino ester)s-based nanovehicles: Structural regulation and gene delivery
por: Zhang, Jiayu, et al.
Publicado: (2023)

Neutrophil Camouflaged Stealth Nanovehicle for Photothermal‐Induced Tumor Immunotherapy by Triggering Pyroptosis
por: Yu, Xuya, et al.
Publicado: (2023)

Self-healing microcapsules synergetically modulate immunization microenvironments for potent cancer vaccination
por: Xi, Xiaobo, et al.
Publicado: (2020)

Synergetics
por: Hutt, Axel, et al.
Publicado: (2020)

Design of a VLP-nanovehicle for CYP450 enzymatic activity delivery
por: Sánchez-Sánchez, Lorena, et al.
Publicado: (2015)

Paclitaxel-Trastuzumab Mixed Nanovehicle to Target HER2-Overexpressing Tumors
por: Nieto, Celia, et al.
Publicado: (2019)

A supramolecular nanovehicle toward systematic, targeted cancer and tumor therapy
por: Liang, Ruizheng, et al.
Publicado: (2015)

Formulation and Applications of Lipid-Based Nanovehicles: Spotlight on Self-emulsifying Systems
por: Mehanna, Mohammed M., et al.
Publicado: (2021)

Magnetic Micellar Nanovehicles: Prospects of Multifunctional Hybrid Systems for Precision Theranostics
por: Miranda, Margarida S., et al.
Publicado: (2022)

Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1
por: Robinson, Edward J., et al.
Publicado: (2018)

Nucleus-selective codelivery of proteins and drugs for synergistic antitumor therapy
por: Yang, Lan, et al.
Publicado: (2022)

Epigenetic Targeting of Mcl-1 Is Synthetically Lethal with Bcl-xL/Bcl-2 Inhibition in Model Systems of Glioblastoma
por: Shang, Enyuan, et al.
Publicado: (2020)

Synergistic Action of MCL-1 Inhibitor with BCL-2/BCL-XL or MAPK Pathway Inhibitors Enhances Acute Myeloid Leukemia Cell Apoptosis and Differentiation
por: Opydo, Małgorzata, et al.
Publicado: (2023)

P-Selectin mediates targeting of a self-assembling phototherapeutic nanovehicle enclosing dipyridamole for managing thromboses
por: Liu, Chia-Hung, et al.
Publicado: (2023)

Closed polymer containers based on phenylboronic esters of resorcinarenes
por: Sergeeva, Tatiana Yu, et al.
Publicado: (2018)

(Trifluoromethoxy)Phenylboronic Acids: Structures, Properties, and Antibacterial Activity
por: Adamczyk-Woźniak, Agnieszka, et al.
Publicado: (2021)

Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
por: Mena, Salvador, et al.
Publicado: (2012)

Glucose‐Sensitive Hydrogel Optical Fibers Functionalized with Phenylboronic Acid
por: Yetisen, Ali K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b62dkt6hrt66aa80g4bk552onc